Recursive partitioning analysis for disease progression in adult intracranial ependymoma patients. (December 2017)

• Record Type: Journal Article
• Authors: Song, Sang Woo; Dho, Yun-Sik; Kim, Jin Wook; Kim, Yong Hwy; Paek, Sun Ha; Kim, Dong Gyu; Jung, Hee-Won; Park, Sung-Hye; Choi, Seung Hong; Kim, Tae Min; Lee, Soon-Tae; Kim, Il Han; Lee, Sang Hyung; Park, Chul-Kee
• Is Part Of: Journal of clinical neuroscience. Volume 46(2017:Dec.)
• Page Start: 72
• Page End: 78
• Publication Date: 2017-12
• Subjects: Ependymoma -- Disease progression -- Prognosis -- Second look surgery; Brain -- Surgery -- Periodicals; Neurosciences -- Periodicals; Nervous system -- Surgery -- Periodicals; Brain -- surgery -- Periodicals; Neurosurgical Procedures -- Periodicals; Neurosciences -- Periodicals; Electronic journals; 616.8
• DOI: 10.1016/j.jocn.2017.08.056
• Languages: English
• ISSNs: 0967-5868

Abstract

Highlights: Risk grouping was performed in adult intracranial ependymomas (EPNs) patients. Degree of resection and tumor location are main splitting criteria in RPA. "Second-look" surgery for residual extraventricular EPNs should be considered. Abstract: Intracranial ependymomas are rare tumors in adults. Although recent advancements from demographic, clinical, and biological studies provide new perspectives on this rare tumor, they are not yet widely applied in clinical practice. Currently, most ependymoma patients are treated in the same way: via surgical resection with adjuvant radiation therapy. However, it is reasonable to apply more aggressive treatment for high-risk patients. From this point of view, we performed a study to investigate risk grouping for disease progression of intracranial ependymomas in adults. A total of 53 patients were included in this study. Data were extracted for patient and tumor characteristics, extent of resection, progression-free survival (PFS), and overall survival. Prognostic variables from univariate and multivariate survival analyses were included in a recursive partitioning analysis for the hierarchical risk grouping of the estimated PFS. Three risk groups were defined based on the clinical prognostic factors. Survival analysis showed significant differences in mean PFS between the different groups: 160.5 ± 22.1 months in the complete resection group, 100.4 ± 36.8 months in the incomplete-resection and intraventricular-location group, and 23.5 ± 6.9 months in the incomplete-resection and extraventricular-location group (p < 0.001). The risk of disease progression in adult intracranial ependymoma patients could be stratified by degree of resection and tumor location. In clinical practice, this result could provide useful information, such as when "second-look" surgery should be performed or whether small tumors invading the fourth ventricle floor should be resected at the expense of neurological deficit.